Issue link: http://deals.uberflip.com/i/1530949
16‐YEAR‐OLD NATIONAL VETERINARY DENTAL EQUIPMENT PROVIDER $1.3M EBITDA—New Jersey US #65905 BUSINESS HIGHLIGHTS Founded in 2007, this highly reputable New Jersey based Company provides the latest generaonal technology for veterinary dental imaging equipment, ergonomic dental tables, and Cone Beam CT (CBCT). By following human dental innovaon this company has worked with OEM manufactures to help develop and source the necessary technology for veterinarians to target and treat their paents. The Company's main product lines include 3‐D CT machines, portable X‐ray machines and digital dental sensors, and a targeted range of ergonomic dental tables allowing for a diverse product offering required by most standard veterinary pracces. The Company's OEM and exclusive products are used by mulple large to small scale veterinary clinics across the United States. The Company maintains a database of approximately 8,000 clients including 2,000 acvely purchasing accounts for 2022 and by offering connuing educaon and seminars to train veterinarians on these new systems as well as product support allows for a high rate of repeat customers (50%+) not offered by other providers. The Company is run by an experienced, knowledgeable, and highly qualified team who stay up to date with the state‐of‐the‐art technology soluons to always find and build the best soluons for their clients. The Company's dynamic team has been a huge driver in the success and growth through a superior reputaon for their extensive knowledge and ability to service and support all their latest generaon technology. This team effort has led to organic demand for their products throughout the veterinary sector. Mark Shortz Senior M&A Advisor Email: mshortz@generaonal.com Mobile: 301‐885‐6503 INVESTMENT BANK OF THE YEAR 2016 - 2017 - 2018 DISCLAIMER: All informaon contained in this document has been provided by the subject company to Generaonal Equity and while believed to be correct has not been independently verified. Accordingly, Generaonal Equity makes no repre‐ sentaons or warranes as to the accuracy and truthfulness of such informaon. The recipient hereof acknowledges that Generaonal Equity shall not be liable for any loss or injury suffered by said recipient in any way connected to the delivery by Generaonal Equity of this document. At all mes Generaonal Equity and/or its affiliate network members are agents for the seller and not for the buyer. Generaonal Equity's fees are paid by the seller. Generaonal Equity 125 Park Avenue , 25th Floor New York, NY 10017 SIGN NDA ► INVESTMENT APPEAL Superior Name and Reputaon. The Company has a 17‐yr long‐standing reputaon for providing superior veterinary dental equipment, soware, and technology training by a highly experienced professional team. High Barriers to Entry. The Company's OEM supplier status, exclusive contracts, and veterinary training programs create a natural barrier of entry to new competors. Outstanding Growth Opportunies. Given sufficient resources, the Company has opportunies to accelerate revenue and profit growth by expanding its customer base geographically, new products, and implemenng a more comprehensive sales and markeng strategy. Significant Industry Experse. In addion to the management team's extensive experience, the Company's key employees are highly trained as veterinary dental experts and technical product support. This wealth of experience and knowledge provides the Company with considerable intangible assets and advantages over many competors. Management Will Remain through Transion. The owners are willing to stay with the Company post‐transacon in order to ensure a seamless transfer of ownership. High Level of Recurring Revenue. Approximately 50% of the Company's annual revenue is derived from repeat clients. Strong Outlook. Due to securing exclusive vendor relaonships, connual growth of client base, strong market demand, and an outstanding reputaon, the Company's revenue is projected to surpass $3.24 Million in current year 2024. Furthermore, adjusted operang profit (EBITDA) margin is forecast to exceed $1.3 Million (31% of sales) in 2024. REVENUE / EBITDA $2.7M 2023 Revenue $910K 2023 EBITDA $3.0M TTM 2024 Revenue $982K TTM 2024 EBITDA REVENUE SOURCES Equipment and Parts 84% Commissions 15% Shipping 1% CUSTOMER ACCOUNTS Acve Clients 2,000 Client Database 8,000 EXPERIENCED TEAM The Company has established a highly experienced and knowledgeable team at delivering consistent success within its industry vercal. This team of five completes a full range of funcons including sales, markeng, customer service, informaon technology, and management. STRATEGIC CLIENTS